KYVERNA THERAPEUTICS Share Price Today: Live Updates & Key Insights
KYVERNA THERAPEUTICS share price today is $7.93, up -7.03%. The stock opened at $8.3 against the previous close of $8.54, with an intraday high of $8.41 and low of $7.92.
KYVERNA THERAPEUTICS Share Price Chart
KYVERNA THERAPEUTICS
KYVERNA THERAPEUTICS Share Price Performance
KYVERNA THERAPEUTICS Institutional Holdings
KYVERNA THERAPEUTICS Market Status
KYVERNA THERAPEUTICS Fundamentals
Market Cap 473.28 M
PB Ratio 3.3501
PE Ratio 0.0
Enterprise Value 307.16 M
Total Assets 304.65 M
Volume 1571693
KYVERNA THERAPEUTICS Company Financials
About KYVERNA THERAPEUTICS & investment objective
Company Information Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Organisation Biotechnology
Employees 129
Industry Biotechnology
CEO Mr. Warner Biddle
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
KYVERNA THERAPEUTICS FAQs
What is the share price of KYVERNA THERAPEUTICS today?
The current share price of KYVERNA THERAPEUTICS is $7.93.
Can I buy KYVERNA THERAPEUTICS shares in India?
Yes, Indian investors can buy KYVERNA THERAPEUTICS shares by opening an international trading and demat account with Motilal Oswal.
How to buy KYVERNA THERAPEUTICS shares in India?
You can easily invest in KYVERNA THERAPEUTICS shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy KYVERNA THERAPEUTICS shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of KYVERNA THERAPEUTICS.
Can I buy fractional shares of KYVERNA THERAPEUTICS?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of KYVERNA THERAPEUTICS?
KYVERNA THERAPEUTICS has a market cap of $473.28 M.
In which sector does KYVERNA THERAPEUTICS belong?
KYVERNA THERAPEUTICS operates in the Biotechnology sector.
What documents are required to invest in KYVERNA THERAPEUTICS stocks?
To invest, you typically need:
What is the PE and PB ratio of KYVERNA THERAPEUTICS?
The PE ratio of KYVERNA THERAPEUTICS is N/A and the PB ratio is 3.35.